TrumpRx Just Cut Ozempic and Wegovy Prices to $350/Month — What GLP-1 Patients Need to Know (2026)

If you've been waiting for GLP-1 drugs to become affordable, the news you've been hoping for just arrived — with caveats. The Trump administration has launched TrumpRx, a federal drug discount initiative featuring negotiated pricing deals with major pharmaceutical manufacturers, including Novo Nordisk and Eli Lilly. The result: Ozempic, Wegovy, and Zepbound are now available for as low as $350 per month through participating pharmacies — a reduction of more than 70% off standard list prices.

For the roughly 40 million uninsured Americans who've watched GLP-1 drugs remain out of reach at $1,000–$1,350 per month, this is a meaningful shift. But the details matter enormously. Here's a complete breakdown of what TrumpRx is, who qualifies, what it covers, and — critically — what it doesn't.

What Is TrumpRx?

TrumpRx is a government-brokered discount platform rather than a direct sales program. Think of it less like Medicare Part D and more like an enhanced version of the existing manufacturer coupon systems, but negotiated at the federal level. The administration announced deals with at least two major GLP-1 manufacturers:

• Novo Nordisk (maker of Ozempic and Wegovy): Discounted pricing through participating retail pharmacies
• Eli Lilly (maker of Zepbound and Mounjaro): Zepbound available at approximately $346/month for eligible patients

The platform works by directing patients to a list of participating pharmacies — both national chains and independent pharmacies — where they can present their TrumpRx eligibility documentation to access the negotiated price. The government does not handle drug dispensing directly.

The New Prices: What You'll Actually Pay

Here's a breakdown of the new TrumpRx pricing compared to standard list prices:

Drug	Standard List Price	TrumpRx Price	Savings
Wegovy (semaglutide 2.4mg)	~$1,350/mo	~$350/mo	74%
Ozempic (semaglutide 1mg)	~$1,000/mo	~$350/mo	65%
Zepbound (tirzepatide)	~$1,086/mo	~$346/mo	68%

These are significant savings. But read the eligibility requirements carefully before assuming you qualify.

Who Qualifies for TrumpRx Pricing?

The TrumpRx program is designed specifically for uninsured, cash-paying patients. If you have private insurance, Medicare, or Medicaid — even if your plan doesn't cover GLP-1s for weight loss — you may not qualify for TrumpRx pricing at all, depending on pharmacy policies.

Eligibility criteria currently include:

• No health insurance, or documented exclusion of GLP-1 coverage by your insurer
• A valid prescription from a licensed U.S. healthcare provider
• Enrollment through a participating pharmacy (not all pharmacies participate yet)

You'll still need a prescription, which means you need a provider relationship. If you don't have one, telehealth GLP-1 programs like Remedy Meds can connect you with a licensed prescriber who can evaluate your eligibility and issue a prescription — often for less than the cost of a traditional in-person visit. That prescription would then be fillable at a TrumpRx-participating pharmacy.

Key Limitations to Understand

The coverage looks compelling on paper, but there are important gaps:

1. Participating pharmacy availability is patchy. Not every pharmacy in every zip code participates in TrumpRx. Rural patients in particular may struggle to find a participating local pharmacy, forcing a mail-order relationship or a long drive.

2. Dose restrictions may apply. The negotiated pricing may cover specific doses or injection pen configurations. Starter doses (used in the titration protocol) may be priced differently than maintenance doses.

3. It doesn't cover the consultation. TrumpRx covers the drug cost only. You still need an initial consultation, ongoing monitoring, and dose adjustments from a provider. These aren't included.

4. Insurance interactions are complex. If you're on an employer plan that technically covers GLP-1s for diabetes but not obesity, you may be locked out of TrumpRx pricing depending on how pharmacies process your claim.

Is $350/Month Actually Cheaper Than Compounded Semaglutide?

This is the question most patients are asking. Until recently, the most affordable route for GLP-1 access was compounded semaglutide — available from telehealth providers for $150–$300/month. TrumpRx brand-name pricing at $350 is higher than most compounded options, but it comes with FDA-approved formulations and no supply uncertainty.

Critically, with the FDA now moving toward enforcement action against compounding pharmacies still producing semaglutide after the official shortage ended, the compounded route is narrowing fast. Brand-name GLP-1s at $350/month may soon be the most affordable legal option available.

For patients who want brand-name access today at the most affordable price, TrumpRx is worth investigating — but pair it with a telehealth provider that can handle the prescription side efficiently. Programs like Remedy Meds work with patients navigating exactly this kind of transition, and can advise on the lowest total-cost path including consultation fees, pharmacy network access, and dose management.

How to Access TrumpRx Pricing

The general process:

1. Confirm you're uninsured or your insurance excludes GLP-1 coverage
2. Get a prescription from a licensed provider (telehealth is fine)
3. Use the TrumpRx pharmacy locator to find a participating pharmacy near you
4. Present your TrumpRx enrollment documentation at the pharmacy
5. Fill your prescription at the negotiated price

Enrollment documentation details are being finalized as the program rolls out. Check the official TrumpRx website for current enrollment requirements in your state.

What This Means for the GLP-1 Market

TrumpRx represents a meaningful shift in the GLP-1 access landscape. It won't solve the problem for everyone — insured patients who still can't get coverage for weight loss indications remain stuck — but for the uninsured, it's a significant price reduction on brand-name products.

For the telehealth industry, the math changes too. Providers who built their business on compounded semaglutide affordability will need to adapt as the price gap between compounded and brand-name narrows (or disappears, once FDA enforcement bites). Expect to see telehealth platforms pivot toward facilitating brand-name prescriptions at TrumpRx pharmacies.

Watch this space. GLP-1 pricing is moving faster than it has at any point since these drugs launched.

Can I use TrumpRx if I have insurance?

Generally, no — the program is designed for uninsured or cash-paying patients. If your insurance covers GLP-1 medications (even partially), you'll typically need to use that coverage. If your insurer specifically excludes GLP-1s for weight loss, you may be able to demonstrate that exclusion to qualify, but policies vary by pharmacy. Confirm with your specific pharmacy before assuming eligibility.

Do I still need a prescription for TrumpRx pricing?

Yes. TrumpRx reduces the drug cost, but it does not eliminate the prescription requirement. You'll need a valid prescription from a licensed U.S. healthcare provider. Telehealth platforms can handle this efficiently — many offer same-week consultations. See our guide to the best online GLP-1 providers for vetted options.

Is $350/month better than compounded semaglutide?

It depends on your situation. Compounded semaglutide is still available (for now) at $150–$300/month through some telehealth providers. However, with FDA enforcement action ramping up against compounding pharmacies, that window is closing. At $350/month, brand-name Wegovy through TrumpRx offers FDA-approved quality with no supply risk — a trade-off increasingly worth making. See our full compounded vs. brand-name semaglutide comparison for a deeper analysis.